Lead Product(s) : N-Desethyloxybutynin
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : New chemical entity and selective muscarinic receptor antagonist targeting large unmet need for a new treatment that can meaningfully improve the lives of patients with neurological conditions.
Product Name : NT0502
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 13, 2020
Lead Product(s) : N-Desethyloxybutynin
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
